Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy

NCT01221181 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01221181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01221181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2010
Completion date
October 31, 2011
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dense deposit disease, membranoproliferative glomerulonephritis